里奥西瓜特对大鼠腺诱导的慢性病的影响
Aly M Abdelrahman1, Raya Al Maskari1, Haytham Ali2
1Department of Pharmacology and Clinical Pharmacy, College of Medicine and Health Sciences, Sultan Qaboos University, P.O. Box 35, Muscat 123, Oman.
Biology
|February 26, 2025
概括
里奥西瓜特是一种可溶性瓜尼酸环酶激活剂,在慢性病 (CKD) 的老鼠模型中表现出保护作用. 它减少了损伤,炎症和氧化应激,这表明它有可能减缓CKD的进展.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
- 心血管研究研究心血管研究
背景情况:
- 循环氨酸单酸盐 (cGMP) 在调节功能方面起着至关重要的作用.
- 慢性病 (CKD) 的特点是慢性损伤和功能受损.
- 溶性酸环酶 (sGC) 激活剂,如里奥西瓜特,增加了cGMP水平.
研究的目的:
- 在慢性脏病 (CKD) 的老鼠模型中研究里奥西瓜特的潜在脏保护作用.
- 评估西瓜特对功能标志物,炎症和腺因诱导的CKD中的氧化应激的影响.
主要方法:
- 慢性病 (CKD) 在雄性Wistar大鼠中被诱导使用腺的管理.
- 鼠被分为四组:对照组,仅氨酸组和氨酸组加上两剂里奥西瓜特 (每天3毫克/公斤和每天10毫克/公斤).
- 治疗时间长达35天,评估血压,功能标志物,炎症性细胞因子,氧化应激标志物和组织病理变化.
主要成果:
- 氨酸诱导的CKD显著增加了缩血压,血肌素,尿素,NGAL,尿中的白蛋白与肌素的比率和NAG,同时降低了肌素清除.
- 组织病理学揭示了腺因治疗的老鼠的管性缩和纤维化,以及IL-1β,IL-6,TNF-α和MDA的升高,以及抗氧化能力的降低 (GR,SOD,CAT,TAC).
- 里奥西瓜特治疗减轻了高血压,改善了功能,减少了损伤标志物,减少了炎症和氧化应激,并改善了他的病理损伤.
结论:
- 里奥西瓜特在老鼠的腺因诱导慢性病 (CKD) 中表现出显著的保护作用.
- 保护机制可能涉及抗炎和抗氧化作用,减轻损伤.
- 里奥西瓜特具有作为治疗剂的潜力,可以减缓慢性病 (CKD) 中损伤的进展.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
370
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
370
Antihypertensive Drugs: Direct Renin Inhibitors
469
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
469
Renal Failure: Dose Adjustments
54
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
54
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
452
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
452
Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
Factors Affecting Renal Clearance: Renal Impairment
48
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
48


